Healthy New Jersey

  • COVID-19 Information
COVID-19 is still active. Wear a mask. Social distance. Stay up to date on vaccine information. Visit:
COVID19 Alert NJDownload free COVID Alert app.
Tropical Storm Ida Recovery

Cannabis Regulatory Commission

Health Research

Abrams, D.I., Jay, C.A., Shade, S.B., Vizoso, H., Reda, H., Press, S., Kelly, M.E., Rowbotham, M.C., & Petersen, K.L. (2007). Cannabis in painful HIV-associated sensory neuropathy: A randomized placebo-controlled trial. Neurology, 68, 515-521. Retrieved from

Amtmann, D., Weydt, P., Johnson K.L., Jensen, M.P., & Carter, G.T. (2004). Survey of cannabis use in patients with amyotrophic lateral sclerosis. American Journal of Hospice and Palliative Medicine, 21(2), 95-104. Retrieved from

Carter, G.T., Abood, M.E., Aggarwal, S.K., & Weiss, M.D. (2010). Cannabis and Amyotrophic Lateral Sclerosis: Hypothetical and practical applications, and a call for clinical trials. American Journal of Hospice & Palliative Medicine, 27(5), 347-356. Retrieved from

Carter, G.T., Flanagan, A.M., Earleywine, M., Abrams, D.I., Aggarwal, S.K., & Grinspoon, L. (2011). Cannabis in palliative medicine: Improving care and reducing opioid-related morbidity. American Journal of Hospice and Palliative Medicine, 28(5), 297-303. Retrieved from

Corey-Bloom, J., Wolfson, T., Gamst, A., Jin, S., Marcotte, T.D., Bentley, H., & Gouaux, B. (2012). Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial. CMAJ, 184(10), 1143-1150. Retrieved from

Degenhardt, L., & Hall, W.D. (2008). Commentary: The adverse effects of cannabinoids: implications for use of medical marijuana. CMAJ, 178(13), 1685-1686. Retrieved from

Ellis, R.J., Toperoff, W., Vaida, F., van den Brande, G., Gonzales, J., Gouaux, B., Bentley, H., & Atkinson, J.H. (2009). Smoked medicinal cannabis for neuropathic pain in HIV: A randomized, crossover clinical trial. Neuropsychopharmacology, 34(3), 672-680. Retrieved from

Grotenhermen, F., & Muller-Vahl, K. (2012). The therapeutic potential of cannabis and cannabinoids. Dtsch Arztebl Int, 109(29-30), 495-501. Retrieved from

Guzman, M., Duarte, M.J., Blazquez, C., Ravina, J., Rosa, M.C., Galve-Roperh, I., Sanchez, C., Velasco, G., & Gonzalez-Feria, L. (2006). A pilot clinical study of Δ 9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. British Journal of Cancer, 95, 197-203. Retrieved from

Haney, M., Gunderson, E., Rabkin, J., Hart, C.L., Vosburg, S., Comer, S., & Foltin, R. (2007). Dronabinol and marijuana in HIV-positive marijuana smokers: Caloric intake, mood and sleep. JAIDS, 45(5), 545-554. Retrieved from arijuana.9.aspx?desktopMode=true

Hazekamp, A., & Grotenhermen, F. (2010). Review on clinical studies with cannabis and cannabinoids 2005-2009. Cannabinoids, 5(special issue), 1-21. Retrieved from

Johnson, J.R., Burnell-Nugent, M., Lossignol. D., Ganae-Motan, E.D., Potts, R., & Fallon, M.T. (2010). Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety and tolerability of THC:CBD extract and THC extract in patients with intractable cancerrelated pain. Journal of Pain and Symptom Management, 39(2), 167-179. Retrieved from

Lueng, L. (2011). Cannabis and its derivatives: Review of medical use. JABFM, 24(4), 452-462. Retrieved from

Merritt, J.C. (1982). Glaucoma, hypertension, and marijuana. Journal of the National Medical Association, 74(8), 715-716. Retrieved from

National Cancer Institute. (2013, January 17 (last modified)). PDQ® Cannabis and Cannabinoids. National Cancer Institute: Bethesda, MD. Retrieved from Accessed January 31, 2013.

Pletcher, M.J.,Vittinghoff, E., Kalhan, R., Richman, J., Safford, M., Sidney, S., Lin, F., & Kerstesz, S. (2012). Association between marijuana exposure and pulmonary function over 20 years. JAMA, 307(2), 173-181. Retrieved from

Strasser, F., Luftner, D., Possinger, K., Ernst, G., Ruhstaller, T., Meissner, W., Ko, Y.-D., Schnelle, M., Reif, M., & Cerny, T. (2006). Comparison of orally administered cannabis extract and delta- 9tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: A multicenter, phase II, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-study-Group. Journal of Clinical Oncology, 24(21), 3394-3400. Retrieved from

Tomida, I., Pertwee, R.G., & Azuara-Blanco, A. (2004). Cannabinoids and glaucoma. Br J Ophthalmol, 88, 708-713. Retrieved from

Wang, T., Collet, J.-P., Shapiro, S., & Ware, M.A. (2008). Adverse effects of medical cannabinoids: A systematic review. CMAJ, 178(13), 1669-1678. Retrieved from

Zajicek, J., Sanders, H.P., Wright, D.E., Vickery, P.J., Ingram, W.M., Reilly, S.M., Nunn, A.J., Teare, L.J., Fox, P.J., & Thompson, A.J. (2005). Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up. J Neurol Neurosurg Psychiatry, 76, 1664-1669. Retrieved from

to top